Xinting T. Sang
Peking Union Medical College Hospital, Peking Union Medical College
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 191 publications
Constructing a protein-protein interaction network for autoimmune liver diseases by integrating pQTL, rQTL, and mediation analyses.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: January 05, 2026
Patient-Derived 3D-Bioprinted Intrahepatic Cholangiocarcinoma Models Recapitulate Tumor Autologous Traits and Predict Personalized Adjuvant Therapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 02, 2025
Exploring the evolving role of apolipoproteins in oncology: global trends and emerging frontiers.
Journal: Journal of cancer research and clinical oncology
Published: August 31, 2025
Evaluation of immune checkpoint inhibitor-associated hepatotoxic adverse events: A pharmacovigilance analysis based on the FAERS database.
Journal: International journal of immunopathology and pharmacology
Published: May 30, 2025
An innovative surgical approach using the hepatic falciform ligament to repair bronchobiliary fistula after radiofrequency ablation: a case report.
Journal: Translational cancer research
Published: May 08, 2025
Urinary biomarkers in cancer detection: explorations, advancements, challenges, and future directions.
Journal: International journal of surgery (London, England)
Published: March 04, 2025
Clinical significance of tumor infiltration length along the bile duct mucosa and submucosa in hilar cholangiocarcinoma.
Journal: Chinese clinical oncology
Published: November 15, 2024
Combined TACE with Targeted and Immunotherapy versus TACE Alone Improves DFS in HCC with MVI: A Multicenter Propensity Score Matching Study.
Journal: Journal of hepatocellular carcinoma
Published: November 15, 2024
Identification of PANoptosis related biomarkers to predict hepatic ischemia‒reperfusion injury after liver transplantation.
Journal: Scientific reports
Published: October 29, 2024
Gut microbiota and metabolite signatures predict severe immune-related adverse events in advanced hepatobiliary cancers.
Journal: Journal of advanced research
Published: September 14, 2024
Effectiveness, safety, and biomarker analysis of lenvatinib plus toripalimab as chemo-free therapy in advanced intrahepatic cholangiocarcinoma: a real-world study.
Journal: Cancer immunology, immunotherapy : CII
Published: August 04, 2024
Last Updated: 09/26/2026